Source: Annual Congress 2006 - Implications of progressive airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ridha, Y. Ferdaous, T. Sofia, C. Amel, B. K. Ali (Ariana, Tunisia). Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2006; 28: Suppl. 50, 3652

Member's Comments

No comment yet.

Related content which might interest you: Antibiotics in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 The efficacy and treatment length of oral corticosteroids in patient with acute exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 295s Year: 2005 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Use of antibiotics in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Pulmonary rehabilitation of patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 The effect of short-acting beta-two-agonist on pulmonary rehabilitation in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009 Bacterial infection in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Evaluation of bronchodilator responses in chronic obstructive pulmonary disease patients Source: Eur Respir J 2002; 20: Suppl. 38, 247s Year: 2002 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Inflammasome activity in acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Acute effects of sildenafil in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Role of inhaled antioxidants in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005